Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Why do our patients get chemotherapy until the end of life?

    Braga S.

    Ann Oncol. 2011 Nov;22(11):2345-8. Epub 2011 Sep 13. No abstract available.

    PMID:
    21917739
    [PubMed - indexed for MEDLINE]
    2.

    Palliative chemotherapy during the last month of life.

    Näppä U, Lindqvist O, Rasmussen BH, Axelsson B.

    Ann Oncol. 2011 Nov;22(11):2375-80. Epub 2011 Mar 14.

    PMID:
    21402621
    [PubMed - indexed for MEDLINE]
    3.

    Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.

    Weberpals JI, Tu D, Squire JA, Amin MS, Islam S, Pelletier LB, O'Brien AM, Hoskins PJ, Eisenhauer EA.

    Ann Oncol. 2011 Nov;22(11):2403-10. Epub 2011 Mar 2.

    PMID:
    21368065
    [PubMed - indexed for MEDLINE]
    4.

    Personalized ovarian cancer treatment.

    Rodriguez AO.

    Curr Opin Obstet Gynecol. 2012 Feb;24(1):1-2. No abstract available.

    PMID:
    22193244
    [PubMed - indexed for MEDLINE]
    5.

    Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.

    Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY, Le XF, Wong OG, Wong ES, Chan HY, Cheung AN.

    Histopathology. 2011 Dec;59(6):1163-72. doi: 10.1111/j.1365-2559.2011.04045.x.

    PMID:
    22175896
    [PubMed - indexed for MEDLINE]
    6.

    Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

    Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, Heinzelmann-Schwarz V.

    Int J Cancer. 2012 Jan 1;130(1):138-46. doi: 10.1002/ijc.26002. Epub 2011 Apr 25.

    PMID:
    21351089
    [PubMed - indexed for MEDLINE]
    7.

    Spectrin αII and βII tetramers contribute to platinum anticancer drug resistance in ovarian serous adenocarcinoma.

    Maeda O, Shibata K, Hosono S, Fujiwara S, Kajiyama H, Ino K, Nawa A, Tamakoshi K, Kikkawa F.

    Int J Cancer. 2012 Jan 1;130(1):113-21. doi: 10.1002/ijc.25983. Epub 2011 Apr 25.

    PMID:
    21328338
    [PubMed - indexed for MEDLINE]
    8.

    Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy.

    Wang D, Saga Y, Mizukami H, Sato N, Nonaka H, Fujiwara H, Takei Y, Machida S, Takikawa O, Ozawa K, Suzuki M.

    Int J Oncol. 2012 Apr;40(4):929-34. doi: 10.3892/ijo.2011.1295. Epub 2011 Dec 13.

    PMID:
    22179492
    [PubMed - in process]
    9.

    Moving beyond anti-vascular endothelial growth factor therapy in ovarian cancer.

    Sood AK, Coleman RL, Ellis LM.

    J Clin Oncol. 2012 Feb 1;30(4):345-7. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184398
    [PubMed - indexed for MEDLINE]
    10.

    Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.

    Karlan BY, Oza AM, Richardson GE, Provencher DM, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippitt CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Nguyen H, Stepan DE, Weinreich DM, Tassoudji M, Sun YN, Vergote IB.

    J Clin Oncol. 2012 Feb 1;30(4):362-71. Epub 2011 Dec 19.

    PMID:
    22184370
    [PubMed - indexed for MEDLINE]
    11.

    Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?

    Halbert CH, Stopfer JE, McDonald J, Weathers B, Collier A, Troxel AB, Domchek S.

    J Clin Oncol. 2011 Nov 10;29(32):4302-6. Epub 2011 Oct 11.

    PMID:
    21990416
    [PubMed - indexed for MEDLINE]
    12.

    Is the easier way ever the better way?

    Chi DS, Bristow RE, Armstrong DK, Karlan BY.

    J Clin Oncol. 2011 Nov 1;29(31):4073-5. Epub 2011 Sep 19. No abstract available.

    PMID:
    21931018
    [PubMed - indexed for MEDLINE]
    13.

    Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.

    Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, Deavers MT, Coleman RL, Lopez-Berestein G, Sood AK.

    J Natl Cancer Inst. 2011 Nov 2;103(21):1596-612. Epub 2011 Sep 28.

    PMID:
    21957230
    [PubMed - indexed for MEDLINE]
    14.

    Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.

    Gotlieb WH, Amant F, Advani S, Goswami C, Hirte H, Provencher D, Somani N, Yamada SD, Tamby JF, Vergote I.

    Lancet Oncol. 2012 Feb;13(2):154-62. Epub 2011 Dec 20.

    PMID:
    22192729
    [PubMed - indexed for MEDLINE]
    15.

    Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.

    Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK.

    Lancet Oncol. 2011 Nov;12(12):1109-17. Epub 2011 Oct 10.

    PMID:
    21992853
    [PubMed - indexed for MEDLINE]
    16.

    Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?

    Chase DM, Fedewa S, Chou TS, Chen A, Ward E, Brewster WR.

    Obstet Gynecol. 2012 Jan;119(1):68-77.

    PMID:
    22183213
    [PubMed - in process]
    17.

    Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.

    Romero IL, McCormick A, McEwen KA, Park S, Karrison T, Yamada SD, Pannain S, Lengyel E.

    Obstet Gynecol. 2012 Jan;119(1):61-7.

    PMID:
    22183212
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk